Research Questions
- Mechanistic link: What are the underlying pathophysiological mechanisms by which single‑chamber leadless pacemakers contribute to persistently elevated hs‑Troponin T, independent of acute coronary syndromes?
- Exercise & pacing dynamics: How do variations in pacing burden, ventricular dyssynchrony, or exercise intensity affect hs‑TnT release in patients with single‑chamber leadless pacemakers compared to non‑paced controls?
- Prognostic value: Can chronic hs‑TnT elevation in leadless pacemaker patients serve as an independent predictor of adverse outcomes (heart failure progression, arrhythmias, or hospitalization) beyond conventional risk factors?
- Device‑related myocardial injury: Does micro‑trauma or chronic mechanical stress at the right ventricular implantation site of leadless pacemakers correlate with measurable increases in hs‑TnT over time?
- Biomarker integration: What is the diagnostic and prognostic utility of combining hs‑TnT with other biomarkers (e.g., NT‑proBNP, high‑sensitivity CRP) in monitoring subclinical myocardial dysfunction in patients with leadless pacemakers?
Tip: If you want, I can convert these questions into an IRB‑ready brief (background, aims, endpoints, statistical plan) or generate a Spanish version for your bilingual pages.